• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau蛋白的翻译后修饰:tau蛋白功能、降解及聚集的动态转变因素

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.

作者信息

Alquezar Carolina, Arya Shruti, Kao Aimee W

机构信息

Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, United States.

出版信息

Front Neurol. 2021 Jan 7;11:595532. doi: 10.3389/fneur.2020.595532. eCollection 2020.

DOI:10.3389/fneur.2020.595532
PMID:33488497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817643/
Abstract

Post-translational modifications (PTMs) on tau have long been recognized as affecting protein function and contributing to neurodegeneration. The explosion of information on potential and observed PTMs on tau provides an opportunity to better understand these modifications in the context of tau homeostasis, which becomes perturbed with aging and disease. Prevailing views regard tau as a protein that undergoes abnormal phosphorylation prior to its accumulation into the toxic aggregates implicated in Alzheimer's disease (AD) and other tauopathies. However, the phosphorylation of tau may, in fact, represent part of the normal but interrupted function and catabolism of the protein. In addition to phosphorylation, tau undergoes another forms of post-translational modification including (but not limited to), acetylation, ubiquitination, glycation, glycosylation, SUMOylation, methylation, oxidation, and nitration. A holistic appreciation of how these PTMs regulate tau during health and are potentially hijacked in disease remains elusive. Recent studies have reinforced the idea that PTMs play a critical role in tau localization, protein-protein interactions, maintenance of levels, and modifying aggregate structure. These studies also provide tantalizing clues into the possibility that neurons actively choose how tau is post-translationally modified, in potentially competitive and combinatorial ways, to achieve broad, cellular programs commensurate with the distinctive environmental conditions found during development, aging, stress, and disease. Here, we review tau PTMs and describe what is currently known about their functional impacts. In addition, we classify these PTMs from the perspectives of protein localization, electrostatics, and stability, which all contribute to normal tau function and homeostasis. Finally, we assess the potential impact of tau PTMs on tau solubility and aggregation. Tau occupies an undoubtedly important position in the biology of neurodegenerative diseases. This review aims to provide an integrated perspective of how post-translational modifications actively, purposefully, and dynamically remodel tau function, clearance, and aggregation. In doing so, we hope to enable a more comprehensive understanding of tau PTMs that will positively impact future studies.

摘要

长期以来,人们一直认为tau蛋白的翻译后修饰(PTM)会影响蛋白质功能并导致神经退行性变。关于tau蛋白潜在的和已观察到的PTM的信息激增,为在tau蛋白稳态的背景下更好地理解这些修饰提供了机会,而tau蛋白稳态会随着衰老和疾病而受到干扰。普遍观点认为,tau蛋白在积累形成与阿尔茨海默病(AD)和其他tau蛋白病相关的有毒聚集体之前会发生异常磷酸化。然而,事实上,tau蛋白的磷酸化可能代表了该蛋白正常但被中断的功能和分解代谢的一部分。除了磷酸化,tau蛋白还会经历其他形式的翻译后修饰,包括(但不限于)乙酰化、泛素化、糖基化、糖基化修饰、SUMO化、甲基化、氧化和硝化。对于这些PTM如何在健康状态下调节tau蛋白以及在疾病中可能被劫持,目前仍缺乏全面的认识。最近的研究强化了这样一种观点,即PTM在tau蛋白的定位、蛋白质 - 蛋白质相互作用、水平维持以及聚集体结构修饰中起着关键作用。这些研究还为神经元可能以潜在的竞争和组合方式主动选择tau蛋白的翻译后修饰方式以实现与发育、衰老、应激和疾病期间独特环境条件相适应的广泛细胞程序提供了诱人线索。在这里,我们综述了tau蛋白的PTM,并描述了目前已知的它们的功能影响。此外,我们从蛋白质定位、静电学和稳定性的角度对这些PTM进行分类,这些因素都有助于tau蛋白的正常功能和稳态。最后,我们评估tau蛋白PTM对tau蛋白溶解度和聚集的潜在影响。tau蛋白在神经退行性疾病生物学中占据着无疑重要的地位。本综述旨在提供一个关于翻译后修饰如何积极、有目的地和动态地重塑tau蛋白功能、清除和聚集的综合观点。通过这样做,我们希望能够更全面地理解tau蛋白的PTM,这将对未来的研究产生积极影响。

相似文献

1
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation.tau蛋白的翻译后修饰:tau蛋白功能、降解及聚集的动态转变因素
Front Neurol. 2021 Jan 7;11:595532. doi: 10.3389/fneur.2020.595532. eCollection 2020.
2
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.Tau蛋白的翻译后修饰及其在阿尔茨海默病病理学中的作用。
Curr Alzheimer Res. 2024;21(1):24-49. doi: 10.2174/0115672050301407240408033046.
3
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein.翻译后的文本: 翻译:翻译后文本 原文:翻译前文本
J Mol Neurosci. 2022 Aug;72(8):1557-1571. doi: 10.1007/s12031-022-02002-0. Epub 2022 Mar 24.
4
Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration.当前技术揭示了翻译后修饰(PTMs)作为神经退行性变关键因素的重要性。
Biomolecules. 2024 Jan 16;14(1):118. doi: 10.3390/biom14010118.
5
A validated antibody panel for the characterization of tau post-translational modifications.用于鉴定 tau 翻译后修饰的经过验证的抗体面板。
Mol Neurodegener. 2017 Nov 21;12(1):87. doi: 10.1186/s13024-017-0229-1.
6
Degradation or aggregation: the ramifications of post-translational modifications on tau.降解或聚集:翻译后修饰对tau蛋白的影响
BMB Rep. 2018 Jun;51(6):265-273. doi: 10.5483/bmbrep.2018.51.6.077.
7
Post-translational modifications: Regulators of neurodegenerative proteinopathies.翻译后修饰:神经退行性蛋白病的调节因子
Ageing Res Rev. 2021 Jul;68:101336. doi: 10.1016/j.arr.2021.101336. Epub 2021 Mar 26.
8
Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein.采用重组蛋白的生物化学方法评估翻译后修饰对致病性 tau 构象的影响。
Biochem Soc Trans. 2024 Feb 28;52(1):301-318. doi: 10.1042/BST20230596.
9
Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.阿尔茨海默病大脑中tau蛋白赖氨酸翻译后修饰的质谱分析
Methods Mol Biol. 2017;1523:161-177. doi: 10.1007/978-1-4939-6598-4_10.
10
Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States.蛋白质半合成提供了获取与 Tau 疾病相关的翻译后修饰(PTMs)的途径,并为在健康和疾病状态下破译 Tau PTM 密码铺平了道路。
J Am Chem Soc. 2018 May 30;140(21):6611-6621. doi: 10.1021/jacs.8b02668. Epub 2018 May 21.

引用本文的文献

1
Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates.tau蛋白病:钙调蛋白调节tau蛋白的过度磷酸化及其向疾病特异性聚集体的转变。
Biomolecules. 2025 Aug 6;15(8):1133. doi: 10.3390/biom15081133.
2
Tau and tauopathies across primate species: implications for modeling neurodegenerative disorders.跨灵长类物种的tau蛋白与tau蛋白病:对神经退行性疾病建模的启示
Front Aging Neurosci. 2025 Jul 23;17:1598245. doi: 10.3389/fnagi.2025.1598245. eCollection 2025.
3
Rational Modulation of Liquid-Liquid Phase Separation Offers Novel Ways to Combat Tauopathies.

本文引用的文献

1
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
2
Cryo-EM structures of tau filaments.tau 纤维的冷冻电镜结构。
Curr Opin Struct Biol. 2020 Oct;64:17-25. doi: 10.1016/j.sbi.2020.05.011. Epub 2020 Jun 27.
3
Semisynthetic Modification of Tau Protein with Di-Ubiquitin Chains for Aggregation Studies.用双泛素链对半合成的 Tau 蛋白进行聚集研究。
液-液相分离的合理调控为对抗tau蛋白病提供了新方法。
Int J Mol Sci. 2025 Jul 12;26(14):6709. doi: 10.3390/ijms26146709.
4
Effect of Tau Fragment and Membrane Interactions on Membrane Permeabilization and Peptide Aggregation.Tau片段与膜相互作用对膜通透性和肽聚集的影响。
Membranes (Basel). 2025 Jul 13;15(7):208. doi: 10.3390/membranes15070208.
5
Chronic Neurobehavioral and Neuropathological Consequences of Repeated Blast Exposure in P301S Transgenic Tau Rats.P301S转基因Tau大鼠反复爆炸暴露后的慢性神经行为和神经病理学后果
Neurotrauma Rep. 2025 Apr 29;6(1):374-390. doi: 10.1089/neur.2024.0168. eCollection 2025.
6
Decoding tau acetylation in Alzheimer's disease and tauopathies: from site-specific mechanisms to therapeutic horizons.解析阿尔茨海默病和tau蛋白病中的tau蛋白乙酰化:从位点特异性机制到治疗前景
BMB Rep. 2025 Aug;58(8):325-339.
7
Antioxidative effects of phytoaromatic compounds on the cysteine of the SKCGS peptide as a critical aggregation domain of tau.植物芳香族化合物对作为tau关键聚集结构域的SKCGS肽半胱氨酸的抗氧化作用。
Sci Rep. 2025 Jul 2;15(1):23206. doi: 10.1038/s41598-025-04999-x.
8
Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials.针对突触核蛋白病和tau蛋白病中患病蛋白的免疫疗法:来自临床试验的见解
Transl Neurodegener. 2025 Jul 1;14(1):33. doi: 10.1186/s40035-025-00490-9.
9
Cytoskeletal Proteins and Alzheimer's Disease Pathogenesis: Focusing on the Interplay with Tau Pathology.细胞骨架蛋白与阿尔茨海默病发病机制:聚焦于与tau病理的相互作用
Biomolecules. 2025 Jun 6;15(6):831. doi: 10.3390/biom15060831.
10
Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer's Disease: The Contribution of Mass Spectrometry-Based Proteomics.磷酸化tau蛋白异构体作为阿尔茨海默病的潜在生物标志物:基于质谱的蛋白质组学的贡献
NeuroSci. 2025 Jun 3;6(2):50. doi: 10.3390/neurosci6020050.
Int J Mol Sci. 2020 Jun 20;21(12):4400. doi: 10.3390/ijms21124400.
4
Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.阿尔茨海默病中清除 Tau 聚集物的自噬途径。
Cell Mol Neurobiol. 2021 Aug;41(6):1175-1181. doi: 10.1007/s10571-020-00897-0. Epub 2020 Jun 11.
5
Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.糖原合酶激酶3(GSK3):其作用与抑制剂
Curr Top Med Chem. 2020;20(17):1522-1534. doi: 10.2174/1568026620666200516153136.
6
The Ubiquitin System in Alzheimer's Disease.阿尔茨海默病中的泛素系统。
Adv Exp Med Biol. 2020;1233:195-221. doi: 10.1007/978-3-030-38266-7_8.
7
Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer's disease patients.阿尔茨海默病患者海马体和前额叶皮层中组蛋白乙酰化途径的失调。
Eur Neuropsychopharmacol. 2020 Apr;33:101-116. doi: 10.1016/j.euroneuro.2020.01.015. Epub 2020 Feb 11.
8
Novel tau filament fold in corticobasal degeneration.新型 tau 丝在皮质基底节变性中的折叠。
Nature. 2020 Apr;580(7802):283-287. doi: 10.1038/s41586-020-2043-0. Epub 2020 Feb 12.
9
Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.翻译后修饰介导了tau蛋白病毒株的结构多样性。
Cell. 2020 Feb 20;180(4):633-644.e12. doi: 10.1016/j.cell.2020.01.027. Epub 2020 Feb 6.
10
Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy.通过自噬溶酶体途径过度活跃的 p300/CBP 促进 tau 分泌和传播在 tau 病中。
Mol Neurodegener. 2020 Jan 6;15(1):2. doi: 10.1186/s13024-019-0354-0.